Volume 25, Number 12—December 2019
Phylogenetic Analysis of Bird-Virulent West Nile Virus Strain, Greece
We report the full polyprotein genomic sequence of a West Nile virus strain isolated from Eurasian magpies dying with neurologic signs in Greece. Our findings demonstrate the local genetic evolution of the West Nile virus strain responsible for a human disease outbreak in the country that began in 2010.
West Nile virus (WNV) is the etiologic agent of an ongoing human disease outbreak in Greece since 2010. Until 2014, successive yearly outbreaks occurred mainly in central and northeastern Greece (1). After a 2-year hiatus, during July–October 2017, an outbreak of the disease occurred in the Peloponnese region in southern Greece that resulted in 48 laboratory-confirmed cases and 5 human deaths (2). In 2018, cases further expanded, with a total of 243 human cases and 50 deaths reported from various areas of Greece (3).
In June 2017, one month before human cases occurred, dead wild birds were reported in the Argolida regional unit in the Peloponnese region of Greece. Through mid-July, local residents noticed a reduction of the native wild bird population, especially Eurasian magpies (Pica pica), hooded crows (Corvus cornix), sparrows (Passer domesticus), and Eurasian collared doves (Streptopelia decaocto). Our team verified the presence of Eurasian magpies with neurologic signs in the area; affected birds were lethargic and unable to fly, stayed low to the ground, and had no reaction to external stimuli (i.e., human presence).
During July and August 2017, we collected a total of 29 dead Eurasian magpies in the study area (Appendix Figure), as part of a monitoring program conducted and supported by the local prefecture since 2016. Twelve of the carcasses were in a condition appropriate for laboratory investigation.
We extracted brain tissue samples during necropsy for inoculation in Vero cell culture. We vortexed brain homogenates in phosphate-buffered saline and centrifuged them at 4,000 × g for 10 min at 4°C. We filtrated 1 mL of brain tissue supernatant with 0.22-μm filters, inoculated it in 75 cm2 flasks with 80% Vero cell confluence, and incubated it at 37°C with 5% CO2 in the appropriate growth medium. We observed the monolayer daily. When we detected cytopathic effect (in 8/12 samples) ≈48 hours after infection, we transferred the flasks to −20°C for 4 hours. After thawing the supernatant and cells, we performed total RNA extraction using the PureLink RNA Mini Kit (Invitrogen, https://www.thermofisher.com).
We amplified the WNV genome by PCR using a set of 14 primer pairs, newly designed or preexisting from related studies targeting overlapping sequences in the WNV genome (Appendix). Amplicons underwent bidirectional sequencing using the fluorescent BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, https://www.thermofisher.com), followed by fragment separation with a 3730xl DNA Analyzer (Applied Biosystems). We verified all nucleotide changes from other WNV strains detected in the 8 positive WNV RNA culture extracts by PCR using the corresponding primers on the tissue extracts. We submitted the consensus sequence, obtained by alignment and assembling in MEGA version 7 software (4), to GenBank (accession no. MH549209) and named it Argolida-Greece-2017.
Results of BLAST sequencing (https://blast.ncbi.nlm.nih.gov/Blast.cgi) showed that the Argolida-Greece-2017 strain had the highest sequence similarity (99.79%) to the Nea Santa-Greece-2010 strain (5) responsible for the largest WNV human disease outbreak since 2010. Phylogenetic analysis confirmed this closer relatedness to the Nea Santa strain than to other strains within the Hungary/04 cluster (Figure). Our findings indicated possible introduction of the Nea Santa strain in the area of southern Greece and the local genetic evolution that took place before reemergence.
The Argolida-Greece-2017 has a total of 23 nt substitutions (3 of them in the 3′ untranslated region of the viral genome) and 4 amino acid changes compared with the phylogenetically closer Nea Santa strain. Amino acid changes include the Ι159Μ in the envelope gene near the NYS glycosylation motif, the H22Y and A298V in the nonstructural (NS) 1 gene, and the K805R mutation in NS5 gene. We predicted that all amino acid changes in the polyprotein gene are tolerated in accordance with the Sorting Tolerant From Intolerant algorithm (6). Although these changes do not seem to affect genetic determinants of virulence as was previously reported (7), further investigation is needed. The presence of proline at the 249 aa position of the NS3 gene is a mutation related to increased viremia potential and virus transmission rates in corvids (8).
In a recent study, Jiménez de Oya et al. performed experimental infection of Eurasian magpies with 2 WNV strains currently circulating in Europe; they found magpies to be highly susceptible to WNV infection, with low survival rates for both strains (9). No WNV-associated bird death had been reported in Greece previously, which could be attributed to the lack of an organized wild bird surveillance system in the country. Nevertheless, mass deaths of Eurasian magpies showing neurologic signs, 1 month earlier than a human neuroinvasive outbreak in the area, demonstrate that monitoring sick birds (e.g., using oral swabs or feather pulp) or carcasses of dead wild birds, in an active and passive surveillance system, could benefit public health by recognizing areas in which prevention measures could be implemented to minimize the impact of WNV human disease outbreaks.
Dr. Valiakos is an assistant professor in the Department of Microbiology and Parasitology, Faculty of Veterinary Medicine, University of Thessaly, Greece. His primary research interests include zoonoses and wildlife animal species that play an important epidemiological role in the transmission of zoonotic diseases, in a One Health approach.
The study was funded by the Prefecture of Peloponnese (Peloponissos A.E.), in the context of project “Monitoring the levels of infectious agents’ circulation and investigating the effect of environmental-hydrological parameters on vectors breeding sites.”
- Gossner CM, Marrama L, Carson M, Allerberger F, Calistri P, Dilaveris D, et al. West Nile virus surveillance in Europe: moving towards an integrated animal-human-vector approach. Euro Surveill. 2017;22:30526.
- Hellenic Centre for Disease Control & Prevention. Annual epidemiological report for West Nile virus human infection, Greece, 2017. 2017 [cited 2019 Oct 1]. https://eody.gov.gr/wp-content/uploads/2019/01/Annual_Report_WNV_2017_ENG_revised_final.pdf
- Hellenic Centre for Disease Control & Prevention. Annual epidemiological report for West Nile virus human infection, Greece, 2017. 2018 [cited 2019 Oct 9]. https://eody.gov.gr/wp-content/uploads/2019/04/Annual_Report_WNV_2018_ENG.pdf
- Kumar S, Stecher G, Tamura K. MEGA7: Molecular Evolutionary Genetics Analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33:1870–4.
- Papa A, Bakonyi T, Xanthopoulou K, Vázquez A, Tenorio A, Nowotny N. Genetic characterization of West Nile virus lineage 2, Greece, 2010. Emerg Infect Dis. 2011;17:920–2.
- Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4:1073–81.
- Botha EM, Markotter W, Wolfaardt M, Paweska JT, Swanepoel R, Palacios G, et al. Genetic determinants of virulence in pathogenic lineage 2 West Nile virus strains. Emerg Infect Dis. 2008;14:222–30.
- Brault AC, Huang CY, Langevin SA, Kinney RM, Bowen RA, Ramey WN, et al. A single positively selected West Nile viral mutation confers increased virogenesis in American crows. Nat Genet. 2007;39:1162–6.
- Jiménez de Oya N, Camacho MC, Blázquez AB, Lima-Barbero JF, Saiz JC, Höfle U, et al. High susceptibility of magpie (Pica pica) to experimental infection with lineage 1 and 2 West Nile virus. PLoS Negl Trop Dis. 2018;12: